Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Baseline characteristics of the study population

From: Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial

Variables Study group (n = 76) Control group (n = 93) p-value
Demographic characteristics
Age (years), mean ± SD 32.50 ± 3.30 31.92 ± 3.68 0.29
BMI (kg/m2), mean ± SD 21.85 ± 2.51 22.24 ± 3.07 0.37
Infertility duration (years), median (IQR) 3 (2, 4) 3 (2, 3) 0.32
Primary infertility, n (%) 48/76 (63.15) 65/93 (69.89) 0.71
Nulliparity, n (%) 72/76 (94.74) 86/93 (92.47) 0.76
Previous ART treatments, n (%) 11/76 (14.47) 20/93 (21.51) 0.43
Ovarian reserve markers
AMH (ng/ml), median (IQR) 0.57 (0.35, 0.80) 0.56 (0.35, 0.80) 0.46
AFC, median (IQR) 5 (3, 6) 4 (3, 6) 0.17
Day 3 FSH (IU/ml), median (IQR) 12.25 (9.39, 15.50) 12.6 (9.95, 15.60) 0.58
Diagnosis of infertility in addition to POR
Tubal factor, n (%) 13/76 (17.11) 22/93 (23.66) 0.61
Male factor, n (%) 22/76 (28.95) 25/93 (26.88) 0.82
Unexplained, n (%) 22/76 (28.95) 25/93 (26.88) 0.82
  1. AMH - anti-Mullerian hormone; AFC - antral follicle count; BMI – body mass index; IQR – interquartile range; POR – poor ovarian reserve; SD – standard deviation